Veeva Systems (NYSE:VEEV) Insider Sells $2,813,300.00 in Stock

Veeva Systems Inc. (NYSE:VEEV) insider Thomas Schwenger sold 10,000 shares of Veeva Systems stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $281.33, for a total value of $2,813,300.00. Following the completion of the sale, the insider owned 19,449 shares in the company, valued at approximately $5,471,587.17. The trade was a 33.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Veeva Systems Price Performance

Shares of Veeva Systems stock opened at $281.25 on Thursday. The business has a 50 day simple moving average of $215.92 and a two-hundred day simple moving average of $186.57. Veeva Systems Inc. has a 12 month low of $148.05 and a 12 month high of $310.50. The stock has a market capitalization of $45.69 billion, a P/E ratio of 46.26, a PEG ratio of 1.19 and a beta of 0.97.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%.The firm had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same period in the previous year, the company posted $1.99 earnings per share. The business’s revenue was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, research analysts anticipate that Veeva Systems Inc. will post 6.7 EPS for the current fiscal year.

Analysts Set New Price Targets

VEEV has been the topic of several research reports. Weiss Ratings raised shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 12th. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research note on Monday, August 3rd. UBS Group boosted their target price on Veeva Systems from $190.00 to $290.00 and gave the stock a “neutral” rating in a report on Thursday, August 27th. The Goldman Sachs Group cut their price target on Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a report on Thursday, June 4th. Finally, BTIG Research reissued a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a research note on Thursday, June 4th. Nineteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $284.46.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Strong results and outlook support the rally. Veeva’s latest quarterly revenue rose 17.6% year over year to $927.96 million, exceeding estimates of $905.38 million. Adjusted earnings of $2.35 per share also topped the $2.23 consensus estimate. The company raised or maintained forward guidance, including fiscal 2027 EPS guidance of approximately $9.21 and third-quarter guidance of $2.33 to $2.34. Veeva Rises on Sales and Margin Gains, Guidance Raise
• Positive Sentiment: Falcon Safety expands Veeva’s AI-driven product offering. The company launched Veeva Falcon Safety, an agentic safety-operations product designed to automate adverse-event intake, case processing, and follow-up across all E2B-compliant safety systems and intake channels. The product could help biopharmaceutical customers reduce costs, improve processing speed, and maintain regulatory compliance, potentially creating additional growth opportunities. Veeva Falcon Safety to Work with All E2B-Compliant Safety Systems Across Any Intake Channels
• Positive Sentiment: Analyst sentiment has improved. An analyst upgrade helped lift investor confidence, while recent price-target increases—including RBC’s target of $325—reinforce the view that earnings momentum may justify additional upside. Veeva Systems Trading Up After Analyst Upgrade
• Neutral Sentiment: Veeva will present at the Wells Fargo 21st Annual Healthcare Conference. The event may provide updates on strategy and demand, but the announcement itself does not change financial forecasts. Veeva to Present at Upcoming Investor Conferences
• Negative Sentiment: Insider selling creates a modest sentiment risk. Exiting President Thomas Schwenger sold 10,000 shares for roughly $2.8 million, reducing his direct holdings substantially. Because the transaction was made under a pre-arranged Rule 10b5-1 plan, it may reflect scheduled portfolio management rather than a negative view of Veeva’s prospects. Veeva’s Exiting President Sold $2.8 Million in Stock
• Negative Sentiment: Investor Michael Burry also trimmed his Veeva position after the stock nearly doubled, potentially adding short-term selling pressure and highlighting concerns about the shares’ elevated valuation.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. Williams Jones Wealth Management LLC. grew its holdings in shares of Veeva Systems by 0.4% in the third quarter. Williams Jones Wealth Management LLC. now owns 9,419 shares of the technology company’s stock valued at $2,806,000 after purchasing an additional 40 shares in the last quarter. Rafferty Asset Management LLC boosted its position in Veeva Systems by 0.7% in the 2nd quarter. Rafferty Asset Management LLC now owns 6,881 shares of the technology company’s stock valued at $1,982,000 after buying an additional 51 shares during the period. Brown Brothers Harriman & Co. grew its stake in shares of Veeva Systems by 8.1% in the third quarter. Brown Brothers Harriman & Co. now owns 719 shares of the technology company’s stock worth $214,000 after acquiring an additional 54 shares in the last quarter. Main Management ETF Advisors LLC increased its position in shares of Veeva Systems by 1.0% during the fourth quarter. Main Management ETF Advisors LLC now owns 5,481 shares of the technology company’s stock worth $1,224,000 after acquiring an additional 56 shares during the period. Finally, Root Financial Partners LLC increased its position in shares of Veeva Systems by 17.1% during the fourth quarter. Root Financial Partners LLC now owns 383 shares of the technology company’s stock worth $85,000 after acquiring an additional 56 shares during the period. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.